Anavex Life Sciences Announces ANAVEX®2-73 (Blarcamesine) Meets Primary and Secondary Endpoints in Placebo-Controlled U.S. Phase 2 Clinical Trial for the Treatment of Adult Patients with Rett Syndrome
https://www.anavex.com/anavex-life-...he-treatment-of-adult-patients-with-rett-syn/
-
- There are more pages in this discussion • 107 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$14.57 |
Change
-0.040(0.27%) |
Mkt cap ! $1.813B | |||
| Open | High | Low | Value | Volume |
| $14.94 | $15.19 | $14.51 | $8.165M | 551.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2735 | $14.55 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.65 | 1396 | 1 |
View Market Depth
| Last trade - 16.10pm 11/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |